C22-Ceramide
C22-Ceramide (Cer d18:1/22:0) is an endogenous bioactive sphingolipid. C22-Ceramide reduces the propensity of C16-ceramide channel formation in isolated rat liver mitochondria and in liposomes[1].
Product Specifications
CAS Number
27888-44-4
Product Name Alternative
N-Behenoyl-D-erythro-sphingosine; Cer d18:1/22:0
UNSPSC
12352211
Target
Liposome
Type
Natural Products
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/c22-ceramide.html
Purity
98.0
Solubility
DMF : 0.33 mg/mL (ultrasonic; warming; heat to 60°C) |Ethanol : 5 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
CCCCCCCCCCCCCCCCCCCCCC(N[C@@H](CO)[C@H](O)/C=C/CCCCCCCCCCCCC)=O
Molecular Formula
C40H79NO3
Molecular Weight
622.06
References & Citations
[1]Stiban J, et al. Very long chain ceramides interfere with C16-ceramide-induced channel formation: A plausible mechanism for regulating the initiation of intrinsic apoptosis. Biochim Biophys Acta. 2015 Feb;1848 (2) :561-7.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC742383-100 1x 100 µL
CD40 / TNFRSF5 / CD40L-Receptor (C40/2383), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
